# EDGAR Filing Document

**Accession Number:** 0002114044
**File Stem:** 0001354457-26-000393
**Filing Date:** 2026-4
**Character Count:** 1167
**Document Hash:** 5fff70dc3fdc6be0fd5f6396d35892d9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001354457-26-000393.hdr.sgml**: 20260430

**ACCESSION NUMBER**: 0001354457-26-000393

**CONFORMED SUBMISSION TYPE**: CERT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260430

**DATE AS OF CHANGE**: 20260430

**EFFECTIVENESS DATE**: 20260430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Hemab Therapeutics Holdings, Inc.
- **CENTRAL INDEX KEY:** 0002114044
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 414241952
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CERT
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43250
- **FILM NUMBER:** 26923452

**BUSINESS ADDRESS:**
- **STREET 1:** 101 MAIN STREET
- **STREET 2:** SUITE 1220
- **CITY:** CAMBRIDGE
- **STATE:** MA
- **ZIP:** 02142
- **BUSINESS PHONE:** 45 2138 7627

**MAIL ADDRESS:**
- **STREET 1:** 101 MAIN STREET
- **STREET 2:** SUITE 1220
- **CITY:** CAMBRIDGE
- **STATE:** MA
- **ZIP:** 02142

### Attached PDF Documents

**Attachment 1:** `COAG_8A_Cert_2114044.pdf`

_No text found in this document._